These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30244816)

  • 21. Ductal carcinoma in situ: treatment or active surveillance?
    Kuerer HM
    Expert Rev Anticancer Ther; 2015; 15(7):777-85. PubMed ID: 25938920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leveraging the variable natural history of ductal carcinoma in situ (DCIS) to select optimal therapy.
    Rojas KE; Fortes TA; Borgen PI
    Breast Cancer Res Treat; 2019 Apr; 174(2):307-313. PubMed ID: 30536119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current controversies in the treatment of ductal carcinoma in situ of the breast.
    Franceschini G; Terribile D; Magno S; Fabbri C; D'Alba P; Chiesa F; Di Leone A; Scafetta I; Masetti R
    Ann Ital Chir; 2008; 79(3):151-5. PubMed ID: 18958961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of subsequent invasive breast cancer after a diagnosis of ductal carcinoma in situ (DCIS).
    Cheung S; Booth ME; Kearins O; Dodwell D
    Breast; 2014 Dec; 23(6):807-11. PubMed ID: 25270228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of ductal carcinoma in situ of the breast: review of recent advances and future prospects.
    Mokbel K
    Int J Fertil Womens Med; 2003; 48(5):217-25. PubMed ID: 14626378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS).
    Groen EJ; Elshof LE; Visser LL; Rutgers EJT; Winter-Warnars HAO; Lips EH; Wesseling J
    Breast; 2017 Feb; 31():274-283. PubMed ID: 27671693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sentinel Node Procedure Obsolete in Lumpectomy for Ductal Carcinoma In Situ.
    Heymans C; van Bastelaar J; Visschers RGJ; Vissers YLJ
    Clin Breast Cancer; 2017 Jun; 17(3):e87-e93. PubMed ID: 28162949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances and controversies in management of breast ductal carcinoma in situ (DCIS).
    Farante G; Toesca A; Magnoni F; Lissidini G; Vila J; Mastropasqua M; Viale G; Penco S; Cassano E; Lazzeroni M; Bonanni B; Leonardi MC; Ripoll-Orts F; Curigliano G; Orecchia R; Galimberti V; Veronesi P
    Eur J Surg Oncol; 2022 Apr; 48(4):736-741. PubMed ID: 34772587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can we know what to do when DCIS is diagnosed?
    Sanders ME; Simpson JF
    Oncology (Williston Park); 2011 Aug; 25(9):852-6. PubMed ID: 21936451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases.
    Goyal A; Douglas-Jones A; Monypenny I; Sweetland H; Stevens G; Mansel RE
    Breast Cancer Res Treat; 2006 Aug; 98(3):311-4. PubMed ID: 16552627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are There Alternative Strategies for the Local Management of Ductal Carcinoma in Situ?
    Rosso KJ; Weiss A; Thompson AM
    Surg Oncol Clin N Am; 2018 Jan; 27(1):69-80. PubMed ID: 29132566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ductal Carcinoma In Situ.
    Fu F; Gilmore RC; Jacobs LK
    Surg Clin North Am; 2018 Aug; 98(4):725-745. PubMed ID: 30005770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. National Breast Cancer Audit: ductal carcinoma in situ management in Australia and New Zealand.
    Cuncins-Hearn A; Boult M; Babidge W; Zorbas H; Villanueva E; Evans A; Oliver D; Kollias J; Reeve T; Maddern G
    ANZ J Surg; 2007; 77(1-2):64-8. PubMed ID: 17295824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study.
    Elshof LE; Schaapveld M; Rutgers EJ; Schmidt MK; de Munck L; van Leeuwen FE; Wesseling J
    Breast Cancer Res; 2017 Mar; 19(1):26. PubMed ID: 28274272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ductal Carcinoma In Situ: Treatment Update and Current Trends.
    Mitchell KB; Kuerer H
    Curr Oncol Rep; 2015 Nov; 17(11):48. PubMed ID: 26373411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Surgical treatment and prognosis of ductal carcinoma in situ: 526 cases analysis].
    Zhu SJ; Chen XS; Wu JY; Huang O; He JR; Zhu L; Chen WG; Li YF; Fei XC; Shen KW
    Zhonghua Wai Ke Za Zhi; 2017 Feb; 55(2):114-119. PubMed ID: 28162210
    [No Abstract]   [Full Text] [Related]  

  • 38. Controversies in the Treatment of Ductal Carcinoma in Situ.
    Barrio AV; Van Zee KJ
    Annu Rev Med; 2017 Jan; 68():197-211. PubMed ID: 28099081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of a prior diagnosis of DCIS on survival from invasive breast cancer.
    Sopik V; Iqbal J; Sun P; Narod SA
    Breast Cancer Res Treat; 2016 Jul; 158(2):385-93. PubMed ID: 27383477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age at diagnosis and outcome for women with ductal carcinoma-in-situ of the breast: a critical review of the literature.
    Vicini FA; Recht A
    J Clin Oncol; 2002 Jun; 20(11):2736-44. PubMed ID: 12039936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.